APA (7th ed.) Citation

Tinhofer, I., Klinghammer, K., Weichert, W., Knödler, M., Stenzinger, A., Gauler, T., . . . Keilholz, U. (2011). Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment. Clinical cancer research, 17(15), . https://doi.org/10.1158/1078-0432.CCR-10-3338

Chicago Style (17th ed.) Citation

Tinhofer, Ingeborg, Konrad Klinghammer, Wilko Weichert, Maren Knödler, Albrecht Stenzinger, Thomas Gauler, Volker Budach, and Ulrich Keilholz. "Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab-docetaxel Treatment." Clinical Cancer Research 17, no. 15 (2011). https://doi.org/10.1158/1078-0432.CCR-10-3338.

MLA (9th ed.) Citation

Tinhofer, Ingeborg, et al. "Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab-docetaxel Treatment." Clinical Cancer Research, vol. 17, no. 15, 2011, https://doi.org/10.1158/1078-0432.CCR-10-3338.